Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biopharma. She joins Maria Whitman to talk about the broader challenges of commercial leadership and what the future might look like as pharma reimagines its commercial model. She also discusses what pharma should do next at a moment when the pace of innovation is incredibly fast and the challenges are unprecedented; why a growth mindset is critical as the industry thinks about the skills and capabilities it needs for the future; and why inclusive leadership is the key to unlocking value for patients.
Transforming Biopharma